glp 1 epilepsy A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 GLP-1 receptor agonists in people

Endocr Rev1999 Feb;20(1):68-100

Chronic exposure to high glucose in intestinal organoids impairs the expression of transcription factors related to the differentiation of early and late endocrine progenitors and L-cell development including Ngn3 and Neurod1

Increase Fibre Gradually Fibre plays a crucial role in: Satiety Gut microbiome health Constipation prevention A general target is: 2535g fibre per day However, fibre should be increased gradually particularly in the first few weeks of treatment

3 The 2025 AAN conference abstract found that MS patients on GLP-1 medications had less disease progression than matched controls, though this preliminary finding needs confirmation in randomised trials

However, this remains speculative without empirical support